CACNA1A-Related Channelopathies: Clinical Manifestations and Treatment Options
Handbook of Experimental Pharmacology · 2023
DOI: 10.1007/164_2022_625 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Handbook of Experimental Pharmacology, 2023. Verfasst von Elisabetta Indelicato und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria. elisabetta.indelicato@i-m…. Hauptthemen laut MEDLINE: Cerebellar Ataxia, Channelopathies, Migraine Disorders. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 147 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria. elisabetta.indelicato@i-med.ac.at.
- Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Zitieren
APA
Indelicato, E., & Boesch, S. (2023). CACNA1A-Related Channelopathies: Clinical Manifestations and Treatment Options. Handbook of Experimental Pharmacology. https://doi.org/10.1007/164_2022_625
Vancouver
Indelicato E, Boesch S. CACNA1A-Related Channelopathies: Clinical Manifestations and Treatment Options. Handbook of Experimental Pharmacology. 2023. doi:10.1007/164_2022_625
BibTeX
@article{Indelicato2023,
author = {Indelicato, Elisabetta and Boesch, Sylvia},
title = {CACNA1A-Related Channelopathies: Clinical Manifestations and Treatment Options},
journal = {Handbook of Experimental Pharmacology},
year = {2023},
doi = {10.1007/164_2022_625}
}
EUVIMED